Mannan treatment induces a decreased phagocytic ability of B10.A and A/J macrophages. by Claudia Feriotti (286149)

A decrease in ACTH plasma concentration was found over time, while serum cortisol concentrations showed a delayed decrease. by Selma van Staveren (5909135)

MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)

MR blockade by anti-MR antibodies decreases the phagocytic and fungicidal abilities and NO production of A/J and B10.A macrophages. by Claudia Feriotti (286149)

IκK-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response - Fig 1 by Norman James Galbraith (4436560)

IκK-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response - Fig 6 by Norman James Galbraith (4436560)

TLR4 expression decreases in B16-OVA tumors. by Andrés H. Rossi (739124)

Schematic representation of the molecular mechanism by which iRF decreases the aggressiveness of B16F10 cells. by Daisy Machado (288559)

Subjects:

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

Knockdown of ErbB2 decreases phosphorylation of Akt and CNC migration. by Ketan Mathavan (4634704)

Positional cloning of <i>qNN1</i> on chromosome 16. by Xinxin Li (281237)

Rdh10a deficient embryos have decreased RA signaling. by Enrico D’Aniello (798447)

LPLI decreases IκBα degradation and NFκB activation. by Jyun-Yi Wu (103136)

<b>Glucagon Clearance is Decreased in Chronic Kidney Disease, but Preserved in Liver Cirrhosis</b> by Magnus F. G. Grøndahl (19160825)

Inhibition of TMEM16A decreased SW620 cell migration and invasion. by Yujie Sui (549090)

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. by Yunseo Woo (6157307)

Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Systemic inhibition of CSF-1R decreases B16F10-induced accumulation of blood monocyte subsets. by Marjolein Sluijter (613087)

Subjects:

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial by José Tarcisio G. Carvalho (4217248)

“…Uremic serum increased the intracellular expression of IL-6, IFN-γ, TLR7, TLR9, VDR, CYP27b1 and CYP24a1. Treatment with 25 or 1,25 vitamin D decreased IL-6 and TLR9. …”